Altus Biolabs GmbH
ATBRA.589223-000
Firmensitz
Dr.-Bohr-Gasse 2-8/13/1
1030 Wien
Vienna
Österreich
Kontakt
Geschäftsführung
Bertram Hausl
Managing Director
Seit 21. September 2022
Lukas Glanz
Managing Director
Seit 21. September 2022
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | ~160.000 € | ~18.980 € | 80.535 € | 4.7% |
| 2023 | ~120.000 € | ~-38.316 € | 58.748 € | -25.9% |
| 2022 | ~120.000 € | ~-11.901 € | 61.203 € | 37.7% |
Branche
NACE 72.11Forschung und Entwicklung im Bereich BiotechnologieWZ 72.1172.11ISIC 7210Research and experimental development on natural sciences and engineeringNAICS 541713Scientific Research and Development ServicesNAICS 541714Scientific Research and Development ServicesNAICS 541715Scientific Research and Development ServicesUKSIC 72.11Research and experimental development on biotechnologyNACE2025 72.10Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Rohdaten
{
"id": "2a31cd59-7012-4399-b7d1-e9a658e02563",
"euId": "ATBRA.589223-000",
"name": "Altus Biolabs GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2022-09-21T00:00:00",
"vatId": "ATU78668719",
"hq": {
"line2": null,
"street": "Dr.-Bohr-Gasse 2-8/13/1",
"city": "Wien",
"zipCode": "1030",
"state": "Vienna",
"country": "AT",
"latitude": 48.189261,
"longitude": 16.4014535
},
"contactData": {
"emails": [
"office@altus-biolabs.com"
],
"phones": [],
"websites": [
"https://hanftest.at/"
],
"faxes": []
},
"managers": [
{
"name": "Bertram Hausl",
"position": "Managing Director",
"startDate": "2022-09-21T00:00:00",
"endDate": null
},
{
"name": "Lukas Glanz",
"position": "Managing Director",
"startDate": "2022-09-21T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"7210"
],
"nace": [
"72.11"
],
"nace2025": [
"72.10"
],
"naics": [
"541713",
"541714",
"541715"
],
"uksic": [
"72.11"
],
"wz": [
"72.11"
]
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 35000,
"capitalIsEstimate": false,
"balanceTotal": 61202.89,
"balanceTotalIsEstimate": false,
"earnings": -11900.61,
"earningsIsEstimate": true,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 120000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -9.917175,
"returnOnSalesIsEstimate": true,
"equity": 23099.39,
"equityIsEstimate": false,
"equityRatio": 37.742319031013075,
"equityRatioIsEstimate": false,
"cash": 24994.33,
"cashIsEstimate": false,
"receivables": 7464.25,
"receivablesIsEstimate": false,
"liabilities": 36303.5,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 35000,
"capitalIsEstimate": false,
"balanceTotal": 58747.78,
"balanceTotalIsEstimate": false,
"earnings": -38316.38,
"earningsIsEstimate": true,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 120000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": true,
"returnOnSales": -31.930316666666663,
"returnOnSalesIsEstimate": true,
"equity": -15216.99,
"equityIsEstimate": false,
"equityRatio": -25.902238348410783,
"equityRatioIsEstimate": false,
"cash": 5869.63,
"cashIsEstimate": false,
"receivables": 15801.59,
"receivablesIsEstimate": false,
"liabilities": 69984.77,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 35000,
"capitalIsEstimate": false,
"balanceTotal": 80535.49,
"balanceTotalIsEstimate": false,
"earnings": 18980.449999999997,
"earningsIsEstimate": true,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 160000,
"revenueIsEstimate": true,
"revenueCagr": 15.470053837925146,
"revenueCagrIsEstimate": true,
"returnOnSales": 11.862781249999998,
"returnOnSalesIsEstimate": true,
"equity": 3763.46,
"equityIsEstimate": false,
"equityRatio": 4.673045386574291,
"equityRatioIsEstimate": false,
"cash": 49020.48,
"cashIsEstimate": false,
"receivables": 2356.63,
"receivablesIsEstimate": false,
"liabilities": 75170.03,
"liabilitiesIsEstimate": false
}
]
}